Healthcare Sector Analytics

Market size, company revenue, drug approvals, clinical trials, regulation, hospitals, doctors, drug spending, labs and devices

Brand drug

Humira(Cf) Pen Psor-Uv-Adol Hs(Adalimumab)AbbVie Inc. logoABBV

Medicare prescription drug cost, prescriptions and prescribers, 2024 · made by AbbVie Inc.

$20.7M

Medicare cost, 2024

Medicare drug plans spent $20.7 million on Humira(Cf) Pen Psor-Uv-Adol Hs (adalimumab) in 2024, for 1,527 prescriptions and refills filled by 1,497 patients. Spending fell 16% from 2023 to 2024. At about $13,581 per prescription it is a high-cost drug. Texas accounts for the most spending ($1.6 million, 8% of the total).

Medicare cost, 2024

$20.7M

-16.0% from 2023

Prescriptions

1,527

$13,580.52 per claim

Patients

1,497

1,223 prescribers

Total spending, 2024

$20.7M

$13,852.68 per patient

Questions and answers

How much does Medicare spend on Humira(Cf) Pen Psor-Uv-Adol Hs?

Medicare prescription drug plans paid $20.7M for Humira(Cf) Pen Psor-Uv-Adol Hs in 2024, for 1,527 prescriptions and refills to 1,497 patients (down 16.0% from 2023). The average cost per claim was $13,580.52.

Which state spends the most on Humira(Cf) Pen Psor-Uv-Adol Hs?

Texas had the highest Medicare cost for Humira(Cf) Pen Psor-Uv-Adol Hs in 2024: $1.6M for 117 claims, followed by North Carolina ($1.2M).

Who prescribes Humira(Cf) Pen Psor-Uv-Adol Hs the most?

Rajiv E Shah, ophthalmology in Winston Salem, NC, had the highest Medicare cost for Humira(Cf) Pen Psor-Uv-Adol Hs in 2024: 21 claims costing $273K.

Who makes Humira(Cf) Pen Psor-Uv-Adol Hs?

Humira(Cf) Pen Psor-Uv-Adol Hs is made by AbbVie Inc. (ABBV), listed in the Medicare spending data as Abbvie US LLC.

Spending over the years

Medicare spending by year

All plans and makers

Prescriber data: cost by year

Medicare spending on Humira(Cf) Pen Psor-Uv-Adol Hs was $20.7M in 2024, after a high of $31.2M in 2021.

By state

Where the prescribers practice, 2024

Medicare cost by state

States with the highest cost

Top prescribers of Humira(Cf) Pen Psor-Uv-Adol Hs, 2024

By Medicare drug cost

PrescriberTypeClaimsPatientsCost
Rajiv E Shah Winston Salem, NCOphthalmology2121$273K

Prescriber data by year

YearPrescribersClaimsPatientsCost
20221,5491,9901,959$26.6M
20231,3711,7031,680$24.7M
20241,2231,5271,497$20.7M

Makers, 2024

Spending by manufacturer as listed in the spending data

ManufacturerClaimsSpending
Abbvie US LLCABBV logoABBV1,527$20.7M

More drugs: Medicare drug spending and the Prescriptions view.

Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.

LinkedInLinkedInXXYouTubeYouTube